United States · Federal contract register · Supplier record

BIOFIRE DIAGNOSTICS LLC

Line: In vitro diagnostic substances, reagents, test kits and sets (6550)Register loaded to September 2026Compiled 17 October 2026

BIOFIRE DIAGNOSTICS LLC — United States · Federal contract register · Supplier record: 891 contracts, all years ($184,906,129 · Sep 2013 – Oct 2026); $9.0M since January 2024 (39 contracts · 2 agencies); 17th rank in the line (of 334 suppliers · 1.3%); 6 agencies never served ($10.9M on the line without BIOFIRE DIAGNOSTICS LLC).

Assay record ASY-US-0HKSA410I0 · Cite as: Assay Systems, “BIOFIRE DIAGNOSTICS LLC: 39 government contracts in the United States since 2024”, https://assay-systems.com/register/us/biofire-diagnostics-llc/

891
contracts, all years
$184,906,129 · Sep 2013 – Oct 2026
$9.0M
since January 2024
39 contracts · 2 agencies
17th
rank in the line
of 334 suppliers · 1.3%
6
agencies never served
$10.9M on the line without BIOFIRE DIAGNOSTICS LLC

Own record by year

2019 onward
$19.2M
$49.8M
$24.7M
$21.7M
$16.9M
$4.8M
$3.4M
$831K
20192020202120222023202420252026

Who buys from BIOFIRE DIAGNOSTICS LLC

since January 2024
2agencies
$9.0Mpaid
99.5%top buyer
Department of Veterans Affairs99.5%
$8,922,768
Department of State0.5%
$47,705

Before 2024 only: Department of Defense, Department of Health and Human Services, General Services Administration.

Won without a rival

2023-10-01 – 2026-06-30
121uncontested awards
67%of its awards
70without a competition
51single bid

BIOFIRE DIAGNOSTICS LLC won 121 of its 181 public contract awards in United States without a rival from 2023-10-01 to 2026-06-30, worth $5.4M: 70 without a competition and 51 after a competition that drew a single bid. 7 buyers awarded it without a rival, the largest Department of Veterans Affairs with 93.

Buyers: Department of Veterans Affairs (93) · Indian Health Service (11) · Department of the Army (6) · Defense Health Agency (4) · Department of State (3) · National Institutes of Health (3)

Every uncontested award of BIOFIRE DIAGNOSTICS LLC · United States: all uncontested awards

The line

since January 2024
$534Mline value
7,757contracts
11agencies
334suppliers
61.1%held by top ten

In vitro diagnostic substances, reagents, test kits and sets (6550)

$229M
$202M
$103M
202420252026Jan–Sep
17thof 334 suppliers
$6,929,416BIOFIRE DIAGNOSTICS LLC in the line
1.3%share of the line
2.1%of $328,152,297 spent by Department of Veterans Affairs

Agencies that buy the line and never bought from BIOFIRE DIAGNOSTICS LLC

6agencies
94contracts
$10,889,559since January 2024
Department of Agriculture64 contracts
$9,629,585
Social Security Administration2 contracts
$574,150
Environmental Protection Agency5 contracts
$327,283
Department of Justice17 contracts
$204,596
Department of the Interior5 contracts
$138,850
Department of Commerce1 contract
$15,095

How the line is bought

by value, since 2024
41%no competition
20%one applicant
0of these to BIOFIRE DIAGNOSTICS LLC
Awarded directly, no competition1,324 contracts
$217,855,440 · 40.8%
Competed, several suppliers applied5,029 contracts
$211,892,122 · 39.7%
Competed, one supplier applied1,404 contracts
$104,594,231 · 19.6%

Contracts reaching their end dates

Oct 2026 – October 2027
536contracts
$121,201,612end by October 2027
102end in September 2027 · $25.8M
6in agencies never served · $416K
$7.9M
$3.5M
$10.8M
$9.0M
$5.4M
$10.1M
$10.8M
$11.4M
$10.2M
$4.6M
$11.8M
$25.8M
Oct 2629 contractsNov 2623 contractsDec 2652 contractsJan 2736 contractsFeb 2737 contractsMar 2757 contractsApr 2740 contractsMay 2739 contractsJun 2745 contractsJul 2722 contractsAug 2754 contractsSep 27102 contracts

Fastest-growing supplier in the line

same line
+135%growth

Supplier UEI PU6HHX2R11C7

2024 to Sep 2026
$42,184,140
2022–2023
$17,936,792

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.